
TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 18
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.539
DO  - doi:10.1002/ejhf.539
SP  - 8
EP  - 521
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Catheterization and Cardiovascular Interventions
JA  - Cathet. Cardiovasc. Intervent.
VL  - 69
IS  - 6
SN  - 1522-1946
UR  - https://doi.org/10.1002/ccd.21200
DO  - doi:10.1002/ccd.21200
SP  - S1
EP  - S96
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Session 2
JO  - European Journal of Heart Failure Supplements
JA  - European Journal of Heart Failure Supplements
VL  - 10
IS  - S1
SN  - 1567-4215
UR  - https://doi.org/10.1093/eurjhf/hsr005
DO  - doi:10.1093/eurjhf/hsr005
SP  - S60
EP  - S104
PY  - 2011
ER  - 

TY  - JOUR
TI  - Maternal Medicine (EP1b)
JO  - BJOG: An International Journal of Obstetrics & Gynaecology
JA  - BJOG: Int J Obstet Gy
VL  - 123
IS  - S2
SN  - 1470-0328
UR  - https://doi.org/10.1111/1471-0528.14104
DO  - doi:10.1111/1471-0528.14104
SP  - 130
EP  - 143
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 20
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.1197
DO  - doi:10.1002/ejhf.1197
SP  - 5
EP  - 638
PY  - 2018
ER  - 

TY  - JOUR
TI  - POSTER SESSION: CLINICAL
JO  - European Journal of Heart Failure
JA  - European Journal of Heart Failure
VL  - 12
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1093/eurjhf/hst009
DO  - doi:10.1093/eurjhf/hst009
SP  - S73
EP  - S325
PY  - 2013
ER  - 

TY  - JOUR
AU  - Kiraly, Laszlo
AU  - Hurt, Ryan T.
AU  - Van Way III, Charles W.
TI  - The Outcomes of Obese Patients in Critical Care
JO  - Journal of Parenteral and Enteral Nutrition
JA  - Journal of Parenteral and Enteral Nutrition
VL  - 35
IS  - 5S
SN  - 0148-6071
UR  - https://doi.org/10.1177/0148607111413774
DO  - doi:10.1177/0148607111413774
SP  - 29S
EP  - 35S
KW  - obesity
KW  - research and diseases
KW  - critical illness
KW  - enteral nutrition
KW  - body mass index
KW  - mortality
PY  - 2011
AB  - The severity and prevalence of obesity continue to rise throughout the world. A similar rise in the prevalence of obesity is seen in the population of patients admitted to the intensive care unit (ICU). In the ICU setting, nearly every aspect of care is made more difficult by obesity. This review highlights the challenges in the care of obese ICU patients. Multiple statistical reviews have suggested improved outcomes for obese ICU patients. This article critically evaluates published outcome studies and highlights potential confounders that may result in misleading results. Body mass index (BMI) has been traditionally used to stratify risk in obese populations. Other factors that may be more predictive of poor outcomes in obese populations are further discussed. Further research in these factors has the potential to guide therapy in high-risk critically ill obese populations.
ER  - 

TY  - JOUR
AU  - Pendergrast, Jacob
AU  - Armali, Chantal
AU  - Cserti-Gazdewich, Christine
AU  - Hansen, Mark
AU  - Kiss, Alex
AU  - Lieberman, Lani
AU  - Parmar, Nagina
AU  - Scales, Damon
AU  - Skeate, Robert
AU  - Callum, Jeannie
AU  - Lin, Yulia
TI  - Can furosemide prevent transfusion-associated circulatory overload? Results of a pilot, double-blind, randomized controlled trial
JO  - Transfusion
JA  - Transfusion
VL  - 59
IS  - 6
SN  - 0041-1132
UR  - https://doi.org/10.1111/trf.15270
DO  - doi:10.1111/trf.15270
SP  - 1997
EP  - 2006
PY  - 2019
AB  - BACKGROUND Transfusion-associated circulatory overload (TACO) is a leading cause of transfusion-attributable morbidity. It is unclear whether diuretics are safe and effective in preventing this reaction. MATERIALS AND METHODS In a pilot controlled feasibility trial, inpatients 65?years or older ordered a single unit of red blood cells were randomized to pre-transfusion furosemide 20?mg or placebo intravenously. Primary outcome was the ability to enroll 80 patients within a 2-month time period. Secondary feasibility outcomes included proportion of RBC transfusions meeting eligibility criteria, proportion of eligible patients enrolled, and compliance to study protocol. Clinical outcomes included the incidence of TACO and associated complications. RESULTS Nine months of enrollment were required for 80 patients to complete the study, due primarily to fewer transfusions than expected meeting eligibility criteria and lower than anticipated consent rates. Protocol compliance was below target due to missing chart documentation of patient fluid balance, and transfusion infusion time. Blinding was maintained throughout the study and treatment arms were well-balanced. A single case of TACO occurred in each arm, for an overall incidence of 2.5%. No differences in peri-transfusion vital signs, B-natriuretic peptide, or signs of furosemide toxicity were observed. CONCLUSION The study protocol was not feasible as designed, primarily due to challenges in patient enrollment. Modifications to trial design to improve feasibility in future studies have been identified.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 17
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.277
DO  - doi:10.1002/ejhf.277
SP  - 5
EP  - 441
PY  - 2015
ER  - 

TY  - JOUR
TI  - 2009 Society for Academic Emergency Medicine (SAEM) Annual Meeting Abstracts
JO  - Academic Emergency Medicine
VL  - 16
IS  - s1
SN  - 1069-6563
UR  - https://doi.org/10.1111/j.1553-2712.2009.00391.x
DO  - doi:10.1111/j.1553-2712.2009.00391.x
SP  - S5
EP  - S273
PY  - 2009
ER  - 

TY  - JOUR
TI  - Oral and Poster Presentations
JO  - Catheterization and Cardiovascular Interventions
JA  - Cathet. Cardiovasc. Intervent.
VL  - 79
IS  - S1
SN  - 1522-1946
UR  - https://doi.org/10.1002/ccd.24386
DO  - doi:10.1002/ccd.24386
SP  - S1
EP  - S110
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 19
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.833
DO  - doi:10.1002/ejhf.833
SP  - 5
EP  - 601
PY  - 2017
ER  - 

TY  - JOUR
TI  - Poster Session 4
JO  - European Journal of Heart Failure Supplements
JA  - European Journal of Heart Failure Supplements
VL  - 10
IS  - S1
SN  - 1567-4215
UR  - https://doi.org/10.1093/eurjhf/hsr009
DO  - doi:10.1093/eurjhf/hsr009
SP  - S166
EP  - S214
PY  - 2011
ER  - 

TY  - JOUR
TI  - Oral Presentations (Clinical Practice/Health)
JO  - Geriatrics & Gerontology International
VL  - 3
IS  - s2
SN  - 1444-1586
UR  - https://doi.org/10.1111/j.1444-1586.2004.70_92.x
DO  - doi:10.1111/j.1444-1586.2004.70_92.x
SP  - s70
EP  - s92
PY  - 2003
ER  - 

TY  - JOUR
TI  - Abstracts from the 14th Congress of the International Society for Rotary Blood Pumps
JO  - Artificial Organs
VL  - 30
IS  - 11
SN  - 0160-564X
UR  - https://doi.org/10.1111/j.1525-1594.2006.00320.x
DO  - doi:10.1111/j.1525-1594.2006.00320.x
SP  - A27
EP  - A50
PY  - 2006
ER  - 

AU  - Del Conde, Ian
AU  - Katzen, Barry T.
C7  - pp. 267-274
TI  - Endovascular Treatment of Pulmonary Embolism
SN  - 9781119283492
UR  - https://doi.org/10.1002/9781119283539.ch22
DO  - doi:10.1002/9781119283539.ch22
SP  - 267-274
KW  - anticoagulation
KW  - catheter-based interventions
KW  - catheter-directed thrombolysis
KW  - inferior vena cava filters
KW  - pulmonary embolism
KW  - RVADs
PY  - 2006
AB  - Summary Pulmonary embolism (PE) presents in a continuum of severity that spans from incidentally discovered subsegmental PE to central or saddle PE that causes cardiogenic shock and sudden death. To date there has been limited dissemination of catheter-based interventions for PE partly due to the lack of prospective randomized controlled clinical trials that demonstrate their efficacy and safety. Catheter-directed thrombolysis (CDT) is rarely used in current practice since it does not appear to offer any meaningful advantages to systemic thrombolysis. Although experience with right ventricular assist devices (RVADs) for the treatment of massive PE is extremely limited, there are case reports that suggest they can be a life-saving intervention in selected cases. Inferior vena cava (IVC) filters are indicated in patients with acute PE who have contraindications to anticoagulation, and in patients with acute PE who have poor cardiopulmonary reserve and who are deemed to be at high risk of death if they develop another PE.
ER  - 

TY  - JOUR
TI  - Abstracts Programme
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 21
IS  - S1
SN  - 9781119283492
UR  - https://doi.org/10.1002/ejhf.1488
DO  - doi:10.1002/ejhf.1488
SP  - 5
EP  - 592
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Session 4
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 16
IS  - s2
SN  - 9781119283492
UR  - https://doi.org/10.1002/ejhf.93_21
DO  - doi:10.1002/ejhf.93_21
SP  - 317
EP  - 365
PY  - 2014
ER  - 

TY  - JOUR
TI  - Oral abstracts
JO  - Vox Sanguinis
VL  - 96
IS  - s1
SN  - 9781119283492
UR  - https://doi.org/10.1111/j.1423-0410.2009.01155.x
DO  - doi:10.1111/j.1423-0410.2009.01155.x
SP  - 1
EP  - 62
PY  - 2009
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Internal Medicine Journal
JA  - Intern Med J
VL  - 46
IS  - S1
SN  - 9781119283492
UR  - https://doi.org/10.1111/imj.13064
DO  - doi:10.1111/imj.13064
SP  - 5
EP  - 25
PY  - 2016
ER  - 
